Methods Of Treating Conditions Related To The S1P1 Receptor

Patent No. EP3242666 (titled "Methods Of Treating Conditions Related To The S1P1 Receptor") was filed by Arena Pharmaceuticals on Jan 6, 2016. The application was issued on Dec 25, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSJul 16, 2025VON KAUFFMANN
MAIWALDJul 15, 2025SELWITSCHKA
SANDOZJul 15, 2025KRAUS & LEDERER PARTGMBB
SYNTHONJul 15, 2025HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3242666

ARENA PHARMACEUTICALS
Application Number
EP16700936A
Filing Date
Jan 6, 2016
Status
Granted And Under Opposition
Sep 13, 2024
Publication Date
Dec 25, 2024